Avricore Financial Statements From 2010 to 2026

Stocks . Canada . 
Stock . Avricore Health
AVCR Stock  CAD 0.07  0.01  7.14%   
Avricore Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avricore Health's valuation are provided below:
Gross Profit
835.5 K
Profit Margin
(0.85)
Market Capitalization
7.6 M
Enterprise Value Revenue
3.8252
Revenue
1.9 M
There are over one hundred nineteen available fundamental signals for Avricore Health, which can be analyzed over time and compared to other ratios. All traders should should validate Avricore Health's prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to climb to about 5.1 M in 2026. Enterprise Value is likely to climb to about 4.7 M in 2026

Avricore Health Total Revenue

5.78 Million

Check Avricore Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avricore Health's main balance sheet or income statement drivers, such as Selling General Administrative of 1.2 M, Other Operating Expenses of 1.7 M or Operating Income of 131.7 K, as well as many indicators such as Price To Sales Ratio of 0.99, Dividend Yield of 0.0 or PTB Ratio of 3.06. Avricore financial statements analysis is a perfect complement when working with Avricore Health Valuation or Volatility modules.
  
This module can also supplement various Avricore Health Technical models . Check out the analysis of Avricore Health Correlation against competitors.

Avricore Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.5 M2.6 M1.7 M
Slightly volatile
Total Current Liabilities407.9 K380.4 K441.7 K
Very volatile
Cash1.4 M1.3 M819.3 K
Pretty Stable
Non Current Assets Total864.1 K822.9 K475.7 K
Slightly volatile
Cash And Short Term Investments639.8 K725.1 K633.9 K
Pretty Stable
Net Receivables500.2 K476.4 K254.2 K
Slightly volatile
Common Stock Shares Outstanding122.3 M116.5 M49.7 M
Slightly volatile
Liabilities And Stockholders Equity3.1 M3 M1.8 M
Slightly volatile
Total Liabilities419.7 K380.4 K444.2 K
Very volatile
Total Current Assets1.2 M1.8 M1.3 M
Pretty Stable
Common Stock20.6 M31.1 M19.9 M
Slightly volatile
Accounts Payable193.2 K294.4 K218.5 K
Slightly volatile
Other Stockholder Equity7.2 M6.7 M8.1 M
Pretty Stable
Accumulated Other Comprehensive Income7.2 M6.8 M4.6 M
Slightly volatile
Other Current Liabilities43.9 K46.3 K137.8 K
Slightly volatile
Other Current Assets33 K34.8 K128.7 K
Slightly volatile
Intangible Assets50.6 K53.2 K413.5 K
Slightly volatile
Short Term Investments8.6 K9 K120.1 K
Slightly volatile
Property Plant Equipment59.8 K104.5 K64 K
Slightly volatile
Capital Stock27.1 M31.4 M23.4 M
Slightly volatile
Short and Long Term Debt Total34.2 K36 K85 K
Pretty Stable
Short Term Debt34.2 K36 K85 K
Pretty Stable
Short and Long Term Debt34.2 K36 K661.6 K
Slightly volatile

Avricore Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.2 M1.9 M1.2 M
Slightly volatile
Other Operating Expenses1.7 M3 M1.9 M
Slightly volatile
Total Operating Expenses5.6 M5.3 M2.3 M
Slightly volatile
Income Tax Expense50.5 K44.2 K65.2 K
Very volatile
Depreciation And Amortization221 K210.5 K111.4 K
Slightly volatile
Total Revenue5.8 M5.5 M1.4 M
Slightly volatile
Gross Profit2.3 M2.2 M518.2 K
Slightly volatile
Selling And Marketing Expenses335.9 K202.4 K201.7 K
Pretty Stable
Research Development303.7 K289.2 K178.2 K
Slightly volatile
Cost Of Revenue3.5 M3.3 M874.4 K
Slightly volatile
Reconciled Depreciation543.6 K517.7 K178.1 K
Slightly volatile

Avricore Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities61.8 K65.1 K1.1 M
Pretty Stable
End Period Cash Flow1.4 M1.3 M819.3 K
Pretty Stable
Begin Period Cash Flow527.4 K318.1 K645.9 K
Very volatile
Depreciation543.6 K517.7 K172.4 K
Slightly volatile
Stock Based Compensation456.2 K622.3 K471.9 K
Very volatile
Change To Netincome857.9 K480.8 K1.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.991.04676
Slightly volatile
Days Sales Outstanding34.9636.8618
Slightly volatile
Average Payables301.8 K287.4 K231.4 K
Slightly volatile
Stock Based Compensation To Revenue0.120.1339.0944
Slightly volatile
Capex To Depreciation0.50.528.2252
Slightly volatile
Inventory Turnover5.4 K5.2 K992
Slightly volatile
Days Of Inventory On Hand0.05450.057312.7 K
Slightly volatile
Payables Turnover10.7310.223.5592
Slightly volatile
Sales General And Administrative To Revenue0.310.3357.3418
Slightly volatile
Research And Ddevelopement To Revenue1.091.02.4107
Slightly volatile
Capex To Revenue0.03670.03861.606
Slightly volatile
Cash Per Share0.01240.01310.0416
Slightly volatile
Days Payables Outstanding27.4928.946.9 K
Slightly volatile
Intangibles To Total Assets0.02810.02960.2052
Slightly volatile
Current Ratio10.465.56.6851
Very volatile
Receivables Turnover10.7810.273.8494
Slightly volatile
Capex Per Share0.00220.00240.006
Slightly volatile
Average Receivables407.3 K387.9 K315.1 K
Slightly volatile
Revenue Per Share0.05210.05490.026
Pretty Stable
Interest Debt Per Share1.0E-41.0E-40.0042
Slightly volatile
Debt To Assets0.01720.01810.2111
Very volatile
Graham Number0.280.320.3482
Slightly volatile
Operating Cycle35.0336.8710.3 K
Slightly volatile
Days Of Payables Outstanding27.4928.946.9 K
Slightly volatile
Long Term Debt To Capitalization0.05060.05680.0621
Slightly volatile
Quick Ratio9.615.56.0291
Very volatile
Net Income Per E B T0.820.991.0698
Slightly volatile
Cash Ratio6.853.944.8586
Very volatile
Days Of Inventory Outstanding0.05450.057312.7 K
Slightly volatile
Days Of Sales Outstanding34.9636.8618
Slightly volatile
Fixed Asset Turnover7.968.385.1141
Pretty Stable
Debt Ratio0.01720.01810.2111
Very volatile
Price Sales Ratio0.991.04676
Slightly volatile
Asset Turnover1.971.870.787
Pretty Stable

Avricore Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.1 M5 M8.9 M
Pretty Stable

About Avricore Health Financial Statements

Avricore Health investors use historical fundamental indicators, such as Avricore Health's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Avricore Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue289.8 K304.3 K
Total Revenue5.5 M5.8 M
Cost Of Revenue3.3 M3.5 M
Stock Based Compensation To Revenue 0.13  0.12 
Sales General And Administrative To Revenue 0.33  0.31 
Research And Ddevelopement To Revenue 1.00  1.09 
Capex To Revenue 0.04  0.04 
Revenue Per Share 0.05  0.05 
Ebit Per Revenue 0.03  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY